Previous 10 | Next 10 |
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies PR Newswire Partnership to Provide Cell and Gene Industry Integrated ...
Syneos Health ( NASDAQ: SYNH ) said it entered a partnership with Shanghai Fosun Pharmaceutical's ( OTCPK:SFOSF ) unit Fosun Pharma USA to launch lung cancer drug serplulimab. Under the agreement, Syneos will provide full-service commercial support through its Syneos One&...
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Fosun Pharma USA Inc. (“Fosun Pharma USA“), the US-based subsidiary of Shangh...
MORRISVILLE, N.C., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 13 th annual Dealmakers’ Intentions Survey. Conducted on an annual basis, the survey provides a review of ...
Syneos Health ( NASDAQ: SYNH ) said Monday that Jason Meggs will step down as chief financial officer on March 31. Meggs will serve as a consultant to the company through the end of 2023. The company said it has retained an executive search firm and has ...
MORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that, effective March 31, 2023, Jason Meggs will transition from his role as Chief Financial Officer to pursue other ca...
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to present at the 41 st Annual J.P. Morgan Healthcare Confe...
Summary I will list major press events shared by Idorsia in 2022. I will offer my readers my personal commentary about each event. I will recap 2022 and comment on what is expected in 2023. Prelude I shared my first article on Idorsia ([[IDRSF]] and IDIA.SW) on Jul...
The shares of Syneos Health ( NASDAQ: SYNH ) fell ~1% pre-market Wednesday after Mizuho Securities downgraded the contract research organization to Neutral from Buy, citing demand headwinds in the CRO space. Issuing the rating change as part of the firm's 2023 Healthcare Services ...
MORRISVILLE, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has extended its strategic partnership with Medable, the industry-leading technology platform for patient-centered cl...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...